Welcome to our dedicated page for Novanta news (Ticker: NOVT), a resource for investors and traders seeking the latest updates and insights on Novanta stock.
Novanta Inc. reports developments as a Nasdaq-listed supplier of core technology solutions for medical, life science and advanced industrial original equipment manufacturers. Its updates center on precision medicine, precision manufacturing, robotics and automation, and advanced surgery, including laser beam steering and scanning, laser sources, robotic and precision motion technologies, medical insufflators, endoscopic pumps and integrated operating room technologies.
Company news commonly covers quarterly earnings releases, conference calls, investor presentations, OEM design wins, product and technology collaborations, and capital actions tied to balance-sheet and securities structure. Recent themes include motion control and sensing technologies for robotics certification environments and tangible equity unit financing.
Novanta Inc. (NASDAQ: NOVT) has announced that Matthijs Glastra will take on the role of Chairman of the Board effective after the Annual Meeting on May 13, 2021. He succeeds Stephen W. Bershad, who retires after 11 years of impactful leadership. Also, Lonny Carpenter will become the independent Lead Director. In recognition of Bershad’s contributions, he will be appointed Chairman Emeritus. Glastra noted that the company is well-positioned for sustained growth, despite challenges posed by the COVID-19 pandemic.
Novanta reported Q4 and full year 2020 results, highlighting revenue of $147.5 million, down 7.6% year-over-year. For the full year, revenue declined 5.7% to $590.6 million. Despite a decrease in organic growth of 10.1% for Q4, operating income rose to $17.1 million, and net income reached $12.7 million. Adjusted diluted EPS for Q4 was $0.53, slightly down from $0.55. The company forecasts Q1 2021 revenue of $155 million to $157 million and plans to launch significantly more new products. Operating cash flow remained strong at $46.6 million for Q4.
Novanta Inc. (Nasdaq: NOVT) will announce its fourth quarter and full year 2020 results on March 1, 2021. A conference call is scheduled for the same day at 10:00 a.m. ET, accessible via phone or through a live webcast on the Company's website. A replay of the call will be available approximately three hours after its conclusion, lasting until April 5, 2021. Novanta is a global supplier of advanced technology solutions that provide OEMs in healthcare and industrial sectors with a competitive edge through precision and technical expertise.
Novanta Inc. (Nasdaq:NOVT), a leader in technology solutions for medical and advanced industrial OEMs, announced that CEO Matthijs Glastra will present at the virtual J.P. Morgan Healthcare Conference on January 13, 2021. Novanta specializes in photonics, vision, and precision motion technologies, providing clients with high-performance sub-systems tailored to their requirements. The company's growth is driven by a team committed to innovation and customer success. For more information, visit www.novanta.com.
Novanta Inc. (Nasdaq: NOVT) announced that its CFO, Robert Buckley, will present at the CJS Securities 21st Annual New Ideas for the New Year Conference on January 13, 2021. Novanta specializes in technology solutions for medical and advanced industrial OEMs, leveraging expertise in photonics, vision, and precision motion. The company focuses on engineering high-performance components and subsystems tailored for demanding applications, contributing to its growth through innovation and customer success.
Novanta Inc. (NASDAQ: NOVT) reported third-quarter 2020 financial results, showing GAAP revenue of $142.9 million, down 7.2% from $154.1 million in Q3 2019. Operating income decreased to $11.9 million, and net income was $8.3 million, compared to $12.8 million and $8.9 million, respectively, in the prior year. Adjusted EBITDA was $30.2 million, slightly lower than $31.0 million in Q3 2019. The company generated significant operating cash flow of $42.1 million, up from $7.0 million last year. Novanta anticipates fourth-quarter revenue of $144-$149 million, with continued focus on product innovation.
Novanta Inc. (Nasdaq: NOVT) announces that CEO Matthijs Glastra and CFO Robert Buckley will present at the Baird Global Industrial Conference on November 11, 2020. The company is renowned for providing core technology solutions, enhancing the competitive edge of medical and industrial OEMs through expertise in photonics, vision, and precision motion. Novanta's common shares are listed on Nasdaq under the ticker symbol 'NOVT'. For more details, visit www.novanta.com.
Novanta Inc. (Nasdaq: NOVT) will release its third quarter 2020 results on November 10, 2020. A conference call to discuss these results is scheduled for the same day at 10:00 a.m. ET. Investors can join by dialing (888) 346-3959 or through a live webcast on the company’s Investor Relations page. A replay of the call will be available three hours post-conclusion until January 4, 2020.
Novanta specializes in technology solutions for healthcare and industrial OEMs.